Skip to main content

Advertisement

SpringerLink
Log in

Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Angiogenesis and arteriogenesis have a crucial role in the formation of coronary collateral vessels. It has been shown that endocan and vascular cell adhesion molecule-1 (VCAM-1) are potential angiogenetic factors. We investigated the relationship between serum endocan levels and grade of coronary collaterals, and also the correlation of endocan levels with serum VCAM-1 levels. Patients with stable angina and at least one total coronary occlusion at invasive coronary angiography were included in our study. Collateral degree was graded according to Rentrop and Cohen’s classification. Patients who had grade 0 or 1 collateral vessels were included in the poorly-developed collateral group, and those with grade 2 or 3 coronary collateral vessels were included in the well-developed collateral group. Serum endocan and VCAM-1 levels were significantly higher in the well-developed collateral group (436.6 ± 213.3 ng/mL vs. 216.1 ± 78.5 ng/mL, p < .001; 11.02 ± 6.58 ng/mL vs. 6.78 ± 1.14 ng/mL, p < .001, respectively). In a logistic regression analysis, only serum endocan level remained as an independent predictor for good collateral development. In the ROC curve analysis, 282 ng/mL endocan level had an a 82 % sensitivity and 86 % specificity for prediction of the well-developed collateral group. Higher endocan level was related to better coronary collateral development. In the event that these results are confirmed in further studies, endocan may be considered as an anti-ischemic treatment strategy in order to improve collateral development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hansen JF (1989) Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion. Am Heart J 117:290–295

    Article  CAS  PubMed  Google Scholar 

  2. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, Lavie P, Roguin A, Levy AP (1999) Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation. Circulation 100:547–552

    Article  CAS  PubMed  Google Scholar 

  3. Simons M (2005) Angiogenesis: where do we stand now? Circulation 111:1556–1566

    Article  PubMed  Google Scholar 

  4. Imhof BA, Aurrand-Lions M (2006) Angiogenesis and inflammation face off. Nat Med 12:171–172

    Article  CAS  PubMed  Google Scholar 

  5. Schaper W, Ito WD (1996) Molecular mechanisms of coronary collateral vessel growth. Circ Res 79:911–919

    Article  CAS  PubMed  Google Scholar 

  6. Schaper W, Buschmann I (1999) Arteriogenesis, the good and bad of it. Cardiovasc Res 43:835–837

    Article  CAS  PubMed  Google Scholar 

  7. Buschmann I, Schaper W (2000) The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 190:338–342

    Article  CAS  PubMed  Google Scholar 

  8. Carmeliet P (2000) Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395

    Article  CAS  PubMed  Google Scholar 

  9. Conway EM, Collen D, Carmeliet P (2001) Molecular mechanisms of blood vessel growth. Cardiovasc Res 49:507–521

    Article  CAS  PubMed  Google Scholar 

  10. Van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, Schaper W (2001) Stimulation of arteriogenesis: a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 49:543–553

    Article  PubMed  Google Scholar 

  11. Kastrup J, Jorgensen E, Drvota V (2001) Vascular growth factor and gene therapy to induce new vessels in the ischemic myocardium: therapeutic angiogenesis. Scand Cardiovasc J 35:291–296

    Article  CAS  PubMed  Google Scholar 

  12. Bechard D, Scherpereel A, Hammad H, Gentina T, Tsicopoulos A, Aumercier M, Pestel J, Dessaint JP, Tonnel AB, Lassalle P (2001) Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-11. J Immunol 167:3099–3106

    Article  CAS  PubMed  Google Scholar 

  13. Roudnicky F, Poyet C, Wild P, Krampitz S, Negrini F, Huggenberger R, Rogler A, Stöhr R, Hartmann A, Provenzano M, Otto VI, Detmar M (2013) Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res 73:1097–1106

    Article  CAS  PubMed  Google Scholar 

  14. Chen LY, Liu X, Wang SL, Qin CY (2010) Over-expression of the Endocan gene in endothelial cells from hepatocellular carcinoma is associated with angiogenesis and tumour invasion. J Int Med Res 38:498–510

    Article  CAS  PubMed  Google Scholar 

  15. Priya MK, Sahu G, Soto-Pantoja DR, Goldy N, Sundaresan AM, Jadhav V, Barathkumar TR, Saran U, Ali BJ, Roberts DD, Bera AK, Chatterjee S (2014) Tipping off endothelial tubes: nitric oxide drives tip cells. Angiogenesis 18(2):175–189

    Article  PubMed  Google Scholar 

  16. Ley K, Laudanna C, Cybulsky MI, Nourshargh S (2007) Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol 7:678–689

    Article  CAS  PubMed  Google Scholar 

  17. Rydeń L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin F (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34(39):3035–3087

    Article  PubMed  Google Scholar 

  18. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M (2013) ESH/ESC Guidelines for the management of arterial hypertension. Eur Heart J 34:2159–2219

    Article  PubMed  Google Scholar 

  19. Gensini GG (1983) A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606

    Article  CAS  PubMed  Google Scholar 

  20. Rentrop KP, Cohen M, Blanke H, Phillips RA (1985) Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 5:587–592

    Article  CAS  PubMed  Google Scholar 

  21. Seiler C (2003) The human coronary collateral circulation. Heart 89(11):1352–1357

    Article  PubMed  PubMed Central  Google Scholar 

  22. Lee W, Ku SK, Kim SW, Bae JS (2014) Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J Cell Physiol 229:620–630

    Article  CAS  PubMed  Google Scholar 

  23. Guray U, Erbay AR, Guray Y, Yilmaz MB, Boyaci AA, Sasmaz H, Korkmaz S, Kutuk E (2004) Poor coronary collateral circulation is associated with higher concentrations of soluble adhesion molecules in patients with single-vessel disease. Coron Artery Dis 15(7):413–417

    Article  PubMed  Google Scholar 

  24. Akboga M, Akyel A, Sahinarslan A, Demirtas C, Yayla C, Boyaci B, Yalcin R (2014) Relationship between plasma apelin level and coronary collateral circulation. Atherosclerosis 235:289–294

    Article  CAS  PubMed  Google Scholar 

  25. Kasapkara HA, Topsakal R, Yarlioglues M, Yarlioglues G, Dogdu O, Ardic I, Akpek M, Kaya MG (2012) Effects of serum uric acid levels on coronary collateral. Coron Artery Dis 23(7):421–425

    Article  PubMed  Google Scholar 

  26. Please provide the details for the reference.

  27. Charney R, Cohen M (1993) The role of the coronary collateral circulation in limiting myocardial ischemia and infarct size. Am Heart J 126:937–945

    Article  CAS  PubMed  Google Scholar 

  28. Waldecker B, Waas W, Haberbosch W, Voss R, Wiecha J, Tillmanns H (2002) Prevalence, and significance of coronary collateral circulation in patients with acute myocardial infarct. Z Kardiol 91:243–248

    Article  CAS  PubMed  Google Scholar 

  29. Meier P, Hemingway H, Lansky AJ, Knapp G, Pitt B, Seiler C (2012) The impact of the coronary collateral circulation on mortality: a meta-analysis. Eur Heart J 33:614–621

    Article  PubMed  Google Scholar 

  30. Regieli JJ, Jukema JW, Nathoe HM, Zwinderman AH, Ng S, Grobbee DE, van der Graaf Y, Doevendans PA (2009) Coronary collaterals improve prognosis in patients with ischemic heart disease. Int J Cardiol 132:257–262

    Article  PubMed  Google Scholar 

  31. Grisar J, Aletaha D, Steiner CW, Kapral T, Steiner S, Seidinger D, Weigel G, Schwarzinger I, Wolozcszuk W, Steiner G, Smolen JS (2005) Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111:204–211

    Article  PubMed  Google Scholar 

  32. Kadı H, Ceyhan K, Karayakalı M, Koç F, Celik A, Onalan O (2011) The relationship between coronary collateral circulation and blood high-sensitivity C-reactive protein levels. Turk Kardiyol Dern Ars 39:23–28

    PubMed  Google Scholar 

  33. Solorio S, Murillo-Ortíz B, Hernández-González M, Guillén-Contreras J, Arenas-Aranda D, Solorzano-Zepeda FJ, Ruiz-Avila R, Mora-Villalpando C, de la Roca-Chiapas JM, Malacara-Hernández JM (2011) Association between telomere length and C-reactive protein and the development of coronary collateral circulation in patients with coronary artery disease. Angiology 62:467–472

    Article  PubMed  Google Scholar 

  34. Kasapkara HA, Topsakal R, Yarlioglues M, Yarlioglues G, Dogdu O, Ardic I, Akpek M, Kaya MG (2012) Effects of serum uric acid levels on coronary collateral circulation in patients with non-ST elevation acute coronary syndrome. Coron Artery Dis 23:421–425

    Article  PubMed  Google Scholar 

  35. Uysal OK, Sahin DY, Duran M, Turkoglu C, Yildirim A, Elbasan Z, Ozkan B, Tekin K, Kunak AU, Yilmaz Y, Kaya MG, Gur M, Cayli M (2014) Association between uric acid and coronary collateral circulation in patients with stable coronary artery disease. Angiology 65(3):227–231

    Article  PubMed  Google Scholar 

  36. Kerner A, Gruberg L, Goldberg A, Roguin A, Lavie P, Lavie L, Markiewicz W, Beyar R, Aronson D (2007) Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am J Cardiol 99(4):509–512

    Article  CAS  PubMed  Google Scholar 

  37. Werner GS, Jandt E, Krack A, Schwarz G, Mutschke O, Kuethe F, Ferrari M, Figulla HR (2004) Growth factors in the collateral circulation of chronic total coronary occlusions: relation to duration of occlusion and collateral function. Circulation 110:1940–1945

    Article  CAS  PubMed  Google Scholar 

  38. Goukassian DA, Qin G, Dolan C, Murayama T, Silver M, Curry C, Eaton E, Luedemann C, Ma H, Asahara T, Zak V, Mehta S, Burg A, Thorne T, Kishore R, Losordo DW (2007) Tumor necrosis factor-alpha receptor p75 is required in ischemia-induced neovascularization. Circulation 115:752–762

    Article  CAS  PubMed  Google Scholar 

  39. Sahinarslan A, Kocaman SA, Topal S, Ercin U, Bukan N, Yalcin R, Timurkaynak T (2010) Relation between serum monocyte chemoattractant protein-1 and coronary collateral development. Coron Artery Dis 21:455–459

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors thank Kamber Kasali for his valuable assistance with the statistical analyses and David F. Chapman for the revision of the paper.

Funding

This research received no grant from any funding agency in the public, commercial or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of Cardiology, School of Medicine, Istanbul University, Capa, 34290, Istanbul, Turkey

    Samim Emet, Ali Elitok, Imran Onur, Mehmet Kocaaga, Ahmet Kaya Bilge, Huseyin Oflaz, Berrin Umman, Aytac Oncul, Zehra Bugra, Kamil Adalet & Fehmi Mercanoglu

Authors
  1. Samim Emet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ali Elitok
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Imran Onur
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mehmet Kocaaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ahmet Kaya Bilge
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huseyin Oflaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Berrin Umman
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Aytac Oncul
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zehra Bugra
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Kamil Adalet
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Fehmi Mercanoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Samim Emet.

Ethics declarations

Conflict of interest

No potential conflict of interest relevant to this article was reported.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Emet, S., Elitok, A., Onur, I. et al. Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion. J Thromb Thrombolysis 43, 60–67 (2017). https://doi.org/10.1007/s11239-016-1424-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-016-1424-6

Keywords

Search

Navigation